5:52 PM
 | 
Feb 05, 2013
 |  BC Extra  |  Financial News

Myriad unveils $200M share buyback

Myriad Genetics Inc. (NASDAQ:MYGN) said its board authorized a $200 million share repurchase program. The company also said...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >